Rebirth of Hong Kong 1981

   Chapter 709 Making medicine is making patents

  The reason why Old Jack agreed to his two daughters and Yang Chen to jointly open a cosmetics company was mainly to win over Yang Chen, a new shareholder of the company, and to increase revenue for the company's open source.

   Earlier, Yang Chen bought a lot of stocks in American pharmaceutical companies. Old Jack's pharmaceutical company was among the several companies that Yang Chen acquired, and it was considered relatively high among the American pharmaceutical companies.

   He holds 18% of the shares of Old Jack's company, which makes Yang Chen the third largest shareholder after Old Jack and the second largest shareholder of the company.

  The pharmaceutical company is the hard work of Old Jack's life. Because he has been focusing on drug research all the year round and neglected in management for a long time, it has caused the second largest shareholder of the company to have undue thoughts.

   If it's just a negligence in management, anyway, the pharmaceutical company was founded by Old Jack, and his influence cannot be overstated.

   Under normal circumstances, even if the second largest shareholder has an idea, it is difficult to replace the position of Old Jack.

   What really worries Old Jack is the company's other shareholders. Because of his emphasis on research, the company spends more on research than other pharmaceutical companies every year.

   Most of the profits of pharmaceutical companies are used by him to invest in drug research every year, so that many shareholders of the company are now dissatisfied with him.

  The company's profits keep increasing every year, but the dividends are still the same. After a long time, no one will be happy.

   In any private company, its shareholders are essentially for the benefit, and whoever wants to hold the company's stock without benefit.

   After feeling the threat, Old Jack did not remain indifferent, and decisively began to win over the directors of the board of directors.

  Although Old Jack focuses on drug research, he is not the kind of doctor who can let go of his rights and devote himself to drug research.

   The pharmaceutical company is his life's work, and he doesn't want to be kicked out of the company and the research laboratory one day.

   Most of the company's shareholders already have opinions on him. Even if he promises that the next research investment will be reduced and the annual profit dividend will be increased, many shareholders who are familiar with him do not believe what he said.

   In the United States, a country where money is paramount, the so-called favor is actually unreliable. As long as it is profitable and deep friendship, people around you can sell you in an instant.

   The old shareholders can't count on them, most of them were bought by the second shareholder, so now Old Jack can only put his hope on the new shareholder Yang Chen.

  Old Jack owns 30% of the company's shares, plus Yang Chen's 18%, and the two add up to 48. The two hold nearly half of the company's shares.

  In this way, unless all the shareholders other than the two join forces, his old Jack is still the major shareholder of the company, a veritable owner.

   Ignoring Whitehead, who was extremely depressed, Old Jack looked at Yang Chen in front of him, and said seriously: "Yang, I agreed to what you said last time. I will hold a board meeting the day after tomorrow to pass your proposal."

   The joy in Yang Chen's eyes flashed away in a flash, he raised his glass, and said with a smile, "That's good, we are happy to work together."

   "Happy cooperation" Old Jack nodded, raised his glass, and drank the red wine in one gulp.

   Seeing the two of them like this, Whitehead swept away the depression in his chest, couldn't help but be curious, and asked, "Old father-in-law, who are you?"

Old Jack said a little unhappily: "Heit, pay attention to your name, if you really like God and them, go after them yourself, if you really have the ability to make their sisters like you, as a father, I also There will be no comments."

   "But that's my father, who won't force his daughter to marry a man he doesn't like."

   Old Jack's words embarrassed Whitehead.

   Seeing that Whitehead didn't dare to talk back at all, Yang Chen made a statement and said, "I intend to establish a Shire pharmaceutical branch in Asia to expand Shire's business to Asia."

   "So it is"

   Whitehead looked at Yang Chen with a grateful expression, Old Jack is the type of when he doesn't care about you, no matter what you say, he can laugh it off, but once he cares about it, it will never end.

Thinking of the situation mentioned by Sister God inadvertently before, Whitehead hesitated and reminded: "Uncle, I have heard from God and the others about the company, but what Shire needs to do now is not to develop new products. Drugs, but as soon as possible financing the acquisition of other pharmaceutical companies to expand the scale.

   Now the government intends to promote the development of the biotechnology industry and the big pharmaceutical companies. If Uncle cannot keep Shire developing at the speed of other pharmaceutical companies, he will soon face the situation of being acquired by the big pharmaceutical companies in the future…”

  The US pharmaceutical industry, after World War II, quickly entered a glorious era, replacing Germany as the world's number one pharmaceutical industry power.

   Driven by the perfect medical insurance in the United States, American pharmaceutical companies have grown rapidly.

  Under the promotion of the government, if pharmaceutical companies want to expand their scale, they can only take the road of merging other pharmaceutical companies. It takes too long to research new drugs.

  Before each new drug enters the market, it needs to undergo rigorous testing and long-term observation.

   Therefore, developing new drugs does not allow a pharmaceutical company to grow rapidly.

   But all large multinational companies are inseparable from all kinds of mergers in the process of growth.

   If a pharmaceutical company wants to expand its scale, only by merging with other pharmaceutical companies and collecting the drug patents and researchers of other pharmaceutical companies can the company's strength be strengthened in a short period of time.

  The rapid development of the pharmaceutical industry in the United States is inseparable from the strict drug patent protection system.

   For a long time, there has been a saying in the United States, "In the United States, to make medicine is to make a patent".

   From the perspective of pharmaceutical companies, new drug R&D is a high-investment and high-risk industry.

   So, it must get super high returns.

  In capitalist countries, capital monopoly is very common. Only monopoly can reap huge profits, and only with huge returns can pharmaceutical companies increase research on new drugs.

   Therefore, American pharmaceutical companies are very keen to extend the term of drug patent protection.

  The patent protection system in the United States has been controversial in later generations. On the one hand, the United States has obtained a lot of money from patents, and on the other hand, because of patent protection, many countries and patients hate it.

  Especially in terms of medicines, all kinds of imported high-priced medicines in later generations, the value of the medicines themselves are very cheap.

The sky-high price medicine is not expensive in the cost of the drug, but in the patent. The same drug is sold in the United States for tens of thousands of dollars, while the generic drugs in Assange’s family only cost tens, hundreds, and tens or hundreds of times in the middle. difference.

   Just because of a patent protection.

  ——

   (end of this chapter)